# Overview of the data being described

- Study design
  - Outbred Drosophila melanogaster population established from a wild-ccaught lineage (Cambridgeshire, UK) in 2017.
  - Three treatments applied to late second/early third instar larvae: wasp homogenate (20 female L. boulardi in 200 μl paraffin), paraffin only (oil), and no manipulation (control).
  - Encapsulation rates measured; 24 hours post manipulation, hemocytes pooled from 100 larvae and fat bodies dissected from 8 larvae.
  - RNA extracted from both tissues and sequenced as 50 bp single-end reads on a single HiSeq4000 lane (June 2019).

- Experimental and sequencing workflow
  - Quality trimming with Trimmomatic (quality < 20 over 4 bp window).
  - Reads mapped to the D. melanogaster reference (r6.28, Flybase) using STAR; mapped reads with MAPQ ≥ 10 counted via featureCounts.
  - Gene filtering: retain genes with at least 10 reads across 12 libraries per tissue; remove fat body genes enriched in salivary glands/male germ cells using FlyAtlas2 data.
  - Differential expression testing (edgeR and limma) with FDR-adjusted P < 0.05 for significance.
  - Gene ontology enrichment tests performed; results reduced with REVIGO.

- Data products and file structure
  - The dataset comprises 13 tables/files (one .txt and twelve .csv):
    - read_count_mq10.txt: read counts per gene for each of 24 samples (12 per tissue) with gene metadata (Geneid, Chr, Start, End, Strand, Length).
    - Library_details.csv: library_ID, Tissue, Treatment plus library preparation conditions.
    - Mapping_metrics.csv: STAR-derived mapping metrics for 24 samples (sample identifiers and 19 metrics).
    - Fatbody_GO.csv: significantly enriched GO terms, KEGG/Reactome, and InterPro categories for 29 upregulated fat-body genes (Flybase IDs listed per category).
    - Hemocytes_GO.csv: significantly enriched GO/Pathway terms for 2,156 upregulated and 1,731 downregulated hemocyte genes; includes enrichment metrics and gene lists.
    - detected_genes.csv: genes detected after filtering for low read support and tissue-specific exclusions; used for downstream analyses.
    - differentially_expressed_genes.csv: differential expression results by tissue and comparison (FB_ID, logFC, AveExpr, t, PValue, adj.P.Val, B).
    - Wasp_specific-Venn.csv: genes unique to wasp homogenate vs control (not differentially expressed in oil vs control) with expression estimates.
    - Wasp_and_Injury-Venn.csv: genes differentially expressed in common to both wasp homogenate vs control and oil vs control, with logFC values per comparison and expression estimates.
    - Oil_Melanization_Phenotype_Characterization.csv: phenotypic counts of melanization for larvae across oil-related treatments.
    - Oil_Injection_Insect_Species_Phenotypes_V3.csv: melanization counts for larvae exposed to homogenates from 44 insect species.
    - Fat_body_qPCR_Confirmation.csv: Ct values for 11 target genes across treatments (oil, oil + wasp homogenate, unchallenged).
    - ProteinaseK_Treatment_post_autoclave_2021_05.csv: melanization counts under four treatments involving wasp homogenate conditions and proteinase K/autoclaving.
    
- Analysis details and criteria
  - Differential expression determined per tissue (hemocytes and fat body) using edgeR/limma with FDR < 0.05.
  - GO and pathway enrichment performed, with redundancy reduced (REVIGO for hemocytes).
  - Data include both transcriptional responses and linked phenotypic assays (melanization) across multiple treatments and species.

- Key findings (high-level)
  - Fat body: 29 upregulated genes in response to wasp homogenate with enriched functional categories.
  - Hemocytes: 2,156 upregulated and 1,731 downregulated genes in response to wasp homogenate vs control, with multiple enriched GO/Pathway terms.
  - Additional analyses include cross-treatment comparisons (wasp vs oil), Venn-based classifications of unique and shared differential expression, and corroborative qPCR data for selected targets.
  - Phenotypic assays document melanization responses under varied treatments and across multiple insect species, providing a link between transcriptional changes and immune-related phenotypes.

- Data governance, metadata, and sharing considerations (relevant to monitoring frameworks)
  - Rich, structured metadata included for libraries, samples, tissues, treatments, and sequencing metrics, enabling reproducibility and re-analysis.
  - Data are organized into clearly defined tables with standardized fields (e.g., sample identifiers, tissue type, treatment, library preparation details, mapping statistics, and differential expression results).
  - Several data items (e.g., underlying gene counts and differential expression results) are suitable for public sharing and integration into dashboards or monitoring dashboards; however, the documentation excerpt does not specify a repository or access status.
  - Metadata adequacy appears strong for verification and reuse, though governance details (ownership, versioning, updates) and explicit data access policies are not described.
  - Transformation steps (quality trimming, normalization, and filtering) are documented, illustrating the importance of data preparation standards in monitoring workflows.
  - Potential barriers identified in monitoring contexts include data accessibility, data silos, and the need to publicly share underlying data to enable external verification and reuse.

- Relevance to monitoring and environmental health frameworks
  - Demonstrates end-to-end data lineage from experimental manipulation to multi-faceted data products (counts, metadata, differential expression, GO enrichments, and phenotypes).
  - Highlights the value of integrating molecular readouts with phenotypic assays to assess host responses to environmental stressors (parasitoid exposure) in model organisms.
  - Emphasizes critical monitoring framework considerations: robust metadata, standardized data processing, clear data governance, and transparent sharing to support decision-making, replication, and future policy-relevant analyses.